Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants
Mast cells are long-lived, granular, myeloid-derived leukocytes that have significant protective and repair functions in tissues. Mast cells sense disruptions in the local microenvironment and are first responders to physical, chemical and biological insults. When activated, mast cells release growt...
Main Authors: | Steven Willows, Marianna Kulka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/12/2713 |
Similar Items
-
Unimpaired Responses to Vaccination With Protein Antigen Plus Adjuvant in Mice With Kit-Independent Mast Cell Deficiency
by: Nadja Schubert, et al.
Published: (2018-08-01) -
From discovery to licensure, the Adjuvant System story
by: Nathalie Garçon, et al.
Published: (2017-01-01) -
The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development
by: Michael Kozak, et al.
Published: (2023-03-01) -
Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
by: E.N. Miyaji, et al.
Published: (2011-06-01) -
Vaccine Adjuvants: from 1920 to 2015 and Beyond
by: Alberta Di Pasquale, et al.
Published: (2015-04-01)